. 2020 Aug 7;23(1):16–23. doi: 10.4103/aja.aja_41_20

Table 3.

Pregnancy outcomes for Menevit users versus controls (no supplements)

Statistical analysis	Subjects, % (n/total)	Univariate		Multivariate^a

		OR (95% CI)	P	OR (95% CI)	P
Biochemical pregnancy rate^b
Control	49.4 (230/466)	1.00		1.00
Menevit	58.3 (77/132)	1.43 (0.97–2.12)	0.069	1.52 (0.99–2.34)	0.053
Clinical viable pregnancy rate^b
Control	38.8 (181/466)	1.00		1.00
Menevit	50.0 (66/132)	1.57 (1.07–2.32)	0.022	1.62 (1.06–2.47)	0.026
Live birth delivery rate^c
Control	38.0 (166/437)	1.00		1.00
Menevit	48.0 (59/123)	1.50 (1.01–2.25)	0.047	1.57 (1.01–2.45)	0.046

Estimates obtained using a binary logistic regression model. ^aAdjusted for maternal age, paternal age, maternal BMI, paternal BMI and the number of oocytes collected; ^bbiochemical and clinical pregnancy rates are expressed per cycle reaching retrieval with at least 1 oocyte collected; ^clive birth delivery rate is expressed per cycle reaching embryo transfer, excluding cycles with total fertilization failure or arrested embryo development. CI: confidence interval; BMI: body mass index; OR: odds ratio